Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_assertion type Assertion NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_head.
- NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_assertion description "[However, when the intra group risk was compared, the risk due to the XPD polymorphic genotypes Lys/Gln or Gln/Gln was significantly lower among familial breast cancer patients compared to sporadic breast cancer patients OR = 0.61; 95%CI = 0.39-0.94; p value = 0.024) whereas the risk implied by XRCC1 variant genotype was not significantly different between the familial and nonfamilial groups of breast cancer patients OR = 0.97; 95%CI = 0.63-1.49; p value = 0.882.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_provenance.
- NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_assertion evidence source_evidence_literature NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_provenance.
- NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_assertion SIO_000772 19051060 NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_provenance.
- NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_assertion wasDerivedFrom gad-20150221 NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_provenance.
- NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_assertion wasGeneratedBy ECO_0000203 NP53664.RA7473252FoG5cAni0AttjKCUL6Xvp6VoIqihyQ7PX4Fg130_provenance.